ANTHONY KULCZYCKI
Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology SAINT LOUIS, MO NPI 1104843630
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology MO GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$1,932.26
- Category: General Payments
- Program years: PY2018–2022
- Record count: 26
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $482.07 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $482.07 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $300.96 | 5 |
| Acerta Pharma LLC | $122.78 | 1 |
| OptiNose US, Inc. | $58.33 | 2 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 914861107 | AstraZeneca Pharmaceuticals LP | $122.78 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 928168053 | OptiNose US, Inc. | $46.51 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 928168107 | OptiNose US, Inc. | $11.82 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944777793 | GlaxoSmithKline, LLC. | $122.78 | 09/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944777797 | GlaxoSmithKline, LLC. | $75.93 | 05/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944777801 | GlaxoSmithKline, LLC. | $2.19 | 11/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944777805 | GlaxoSmithKline, LLC. | $4.86 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944777809 | GlaxoSmithKline, LLC. | $95.20 | 03/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.